Sign in

NCT06809647Not yet recruiting

A Prospective Interventional Cohort Study to Evaluate the Efficacy and Safety of the AquaLumen, a Novel Filtration Procedure for the Treatment of Open Angle Glaucoma

Source: ClinicalTrials.gov · Last updated 5 Feb 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The study will follow a group of patients with glaucoma disease that undergo a surgical procedure intended to reduce the intra-ocular pressure (IOP) for a period of one year.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
10 (estimated)
First submitted
30 Jan 2025
Start date
30 Mar 2025
Primary completion date
30 Jun 2026
Lead sponsor
PLU Ophthalmic
Diseases
Glaucoma
NCT number
NCT06809647

What you commit to

  • Study type: Interventional
  • Planned participants: 10
  • From 30 Mar 2025 to the primary completion date, 30 Jun 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Failed prior trabeculectomy

Other illness

  • surgical history of corneal graft

Other

  • presence of corneal opacities

Who the study is looking for

  • Moderate to severe open angle glaucoma
  • Central corneal thickness between 480 and 610 microns

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
MUSC Storm Eye Institute
Coordinator of this site? Confirm its status
CharlestonUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.